Objective. The increasing focus on health care costs requires that all phys
icians evaluate practice behaviors. The primary emphasis in anesthesia has
been limiting the use of expensive medications and interventions. Reducing
waste is another approach, and volatile anesthetics are an appropriate targ
et in that simple reduction of fresh gas flow (FGF) rates is effective. A m
onitor that measures and displays the cost of wasted volatile anesthetic wa
s developed and used to determine if real-time display of the cost would re
sult in decreased FGF rates, which, in turn, would decrease wasted anesthet
ic. Methods. The waste gas monitor (WGM) measures flow rate at the anesthes
ia machine's scavenger port, integrates this with agent concentration, and
displays the calculated cost, real-time, on a portable computer screen. The
WGM equipment was attached to the anesthesia machine in the gynecologic su
rgery operating room (OR) and those cases performed under general endotrach
eal anesthesia and lasting longer than one hour were eligible for inclusion
. First year anesthesiology residents assigned to the study OR as part of a
non-specialty rotation, were the subjects of the study. For each resident,
after data were collected from at least two eligible baseline cases (Basel
ine Phase, WGM not visible and resident unaware of its presence), the monit
or was introduced and data collection continued for at least three more eli
gible cases (Visible Phase). Results. Nine residents were initially enrolle
d, but due to scheduling difficulties only five residents completed the pro
tocol. Data from cases using the WGM demonstrated a 50% decrease (3.58 +/-
1.34 l/min vs. 1.78 +/- 0.51 l/min (p = 0.009)) in the scavenger flow rates
, which resulted in a 48% ($5.28 +/- 0.68 vs. $2.72 +/- 0.80 (p = 0.002)) d
ecrease in hourly cost of wasted volatile anesthetic. There was no differen
ce between the Baseline and Visible phases with regard to use of nitrous ox
ide or intravenous anesthetic agents. Conclusions. The WGM decreased wasted
volatile anesthetic by encouraging decreased FGF rates.